Pomalidomide Shows Significant Therapeutic Activity against CNS Lymphoma with a Major Impact on the Tumor Microenvironment in Murine Models

Overview of attention for article published in PLOS ONE, August 2013

Altmetric Badge

Mentioned by

news: 7 news outlets
blogs: 1 blog

twitter: 7 X users

Citations

dimensions_citation: 87 Dimensions

Readers on

mendeley: 54 Mendeley

Summary News Blogs X Dimensions citations

So far, Dimensions has found 87 publications that cite this research output.

87

The most recent citing publications are shown below. View all 87 publications that cite this research output on Dimensions.

Targets and treatments in primary CNS lymphoma

Article in Leukemia & Lymphoma (April 2024)

Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis

Article in Journal of Clinical Neuroscience (April 2024)

Pomalidomide improves the effectiveness of CAR-T treatment in the relapsed and refractory multiple myeloma or B-cell leukemia/lymphoma with extramedullary disease

Article in Blood Science (April 2024)